Differentiation of small bowel and pancreatic neuroendocrine tumors by gene-expression profiling

Surgery (United States)

Volumn 152, Issue 6, 2012, Pages 998-1007

  Carr, Jennifer C ^a   Boese, Erin A ^b   Spanheimer, Philip M ^a   Dahdaleh, Fadi S ^a   Martin, Molly ^b   Calva, Daniel ^a   Schafer, Blanca ^b   Thole, David M ^c   Braun, Terry ^c   O'Dorisio, Thomas M ^b   O'Dorisio, M Sue ^b   Howe, James R ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADORA1 GENE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENOME ANALYSIS; GPCR GENE; GPR113 GENE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; OXTR GENE; PANCREATIC NEUROENDOCRINE TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEPTOR GENE; RNA EXTRACTION; SCTR GENE; SMALL INTESTINE TUMOR; TUMOR DIFFERENTIATION; UPREGULATION;

GENE EXPRESSION PROFILING; HUMANS; INTESTINAL NEOPLASMS; INTESTINE, SMALL; LIVER NEOPLASMS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84869453676     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2012.08.040     Document Type: Article

References (24)

1. J.C. Yao, M. Hassan, and A. Phan One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States J Clin Oncol 26 2008 3063 3072
2. D. O'Toole, A. Grossman, and D. Gross ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers Neuroendocrinology 90 2009 194 202
3. I.M. Modlin, K.D. Lye, and M. Kidd A 5-decade analysis of 13,715 carcinoid tumors Cancer 97 2003 934 959
4. S.C. Wang, J.R. Parekh, and M.B. Zuraek Identification of unknown primary tumors in patients with neuroendocrine liver metastases Arch Surg 145 2010 276 280
5. F.S. Dahdaleh, D. Calva-Cerqueira, and J.C. Carr Comparison of clinicopathologic factors in 122 patients with resected pancreatic and ileal neuroendocrine tumors from a single institution Ann Surg Oncol 19 2011 966 972
6. A. Rinke, H.-H. Muller, and C. Schade-Brittinger Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group J Clin Oncol 27 2009 4656 4663
7. M.S. Khan, and M.E. Caplin Therapeutic management of patients with gastroenteropancreatic neuroendocrine tumours Endocr Relat Cancer 18 Suppl 1 2011 S53 S74
8. J.C. Yao, M.H. Shah, and T. Ito Everolimus for advanced pancreatic neuroendocrine tumors N Engl J Med 364 2011 514 523
9. E. Raymond, L. Dahan, and J.L. Raoul Sunitinib malate for the treatment of pancreatic neuroendocrine tumors N Engl J Med 364 2011 501 513
10. E.M. Duerr, Y. Mizukami, and A. Ng Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis Endocr Relat Cancer 15 2008 243 256
11. E. Missiaglia, I. Dalai, and S. Barbi Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway J Clin Oncol 28 2010 245 255
12. I. Drozdov, B. Svejda, and B.I. Gustafsson Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia PLoS One 6 2011 e22457
13. K. Edfeldt, P. Bjorklund, G. Akerstrom, G. Westin, P. Hellman, and P. Stalberg Different gene expression profiles in metastasizing midgut carcinoid tumors Endocr Relat Cancer 18 2011 479 489
14. N. Posorski, D. Kaemmerer, and G. Ernst Localization of sporadic neuroendocrine tumors by gene expression analysis of their metastases Clin Exp Metastasis 28 2011 637 647
15. Zhang J, Ruschhaupt M, Biczok R. ddCt method for qRT-PCR data analysis. 2011. Available at http://www.bioconductor.org/packages/2.9/bioc/vignettes/ddCt/ inst/doc/rtPCR.pdf, 2012.
16. M.J. de Hoon, S. Imoto, J. Nolan, and S. Miyano Open-source clustering software Bioinformatics 20 2004 1453 1454
17. J.P. Brunet, P. Tamayo, T.R. Golub, and J.P. Mesirov Metagenes and molecular pattern discovery using matrix factorization Proc Natl Acad Sci U S A 101 2004 4164 4169
18. P. Buckhaults, Z. Zhang, and Y.C. Chen Identifying tumor origin using a gene expression-based classification map Cancer Res 63 2003 4144 4149
19. A. Couvelard, J. Hu, and G. Steers Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors Gastroenterology 131 2006 1597 1610
20. W.G. Dilley, S. Kalyanaraman, S. Verma, J.P. Cobb, J.M. Laramie, and T.C. Lairmore Global gene expression in neuroendocrine tumors from patients with the MEN1 syndrome Mol Cancer 4 2005 9
21. G. Capurso, S. Lattimore, and T. Crnogorac-Jurcevic Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets Endocr Relat Cancer 13 2006 541 558
22. M. Bloomston, A. Durkin, and I. Yang Identification of molecular markers specific for pancreatic neuroendocrine tumors by genetic profiling of core biopsies Ann Surg Oncol 11 2004 413 419
23. R. Heilker, M. Wolff, C.S. Tautermann, and M. Bieler G-protein-coupled receptor-focused drug discovery using a target class platform approach Drug Discov Today 14 2009 231 240
24. B. Givi, S.J. Pommier, A.K. Thompson, B.S. Diggs, and R.F. Pommier Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival Surgery 140 2006 891 897